Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM
Clinical trial NCT05677334 · COMPLETED
Trial details
- NCT number
- NCT05677334
- Sponsor
- First Affiliated Hospital of Guangxi Medical University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2024-10-30
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.